MDxHealth SA (MDXH)
NASDAQ: MDXH · Real-Time Price · USD
0.5659
-0.0341 (-5.68%)
At close: Jun 5, 2026, 4:00 PM EDT
0.5796
+0.0137 (2.42%)
After-hours: Jun 5, 2026, 7:58 PM EDT

MDxHealth Stock Forecast

MDXH's stock price has decreased by -73.56% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

According to 6 analysts polled by S&P Global, MDxHealth stock has a consensus rating of "Strong Buy" and an average price target of $3.90. The average 1-year stock price forecast is 589.17% higher than the current stock price, while the lowest is $1.50 (+165.06%) and the highest is $6.00 (+960.26%).

Price Target: $3.90 (+589.17%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$1.50$3.90$4.00$6.00
Change+165.06%+589.17%+606.84%+960.26%

Analyst Ratings

The average analyst rating for MDxHealth stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingDec '25Jan '26Feb '26Mar '26Apr '26May '26
Strong Buy666665
Buy000000
Hold000001
Sell000000
Strong Sell000000
Total666666

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Lake Street
Lake Street
Buy
Maintains
$9$5
BuyMaintains$9$5+783.55%May 14, 2026
William Blair
William Blair
Hold
Downgrades
n/a
HoldDowngradesn/an/aMay 14, 2026
Craig-Hallum
Craig-Hallum
Buy
Maintains
$3
BuyMaintains$3+430.13%May 14, 2026
BTIG
BTIG
Buy
Reiterates
$7$4
BuyReiterates$7$4+606.84%May 14, 2026
TD Cowen
TD Cowen
Buy
Maintains
$7$1.5
BuyMaintains$7$1.5+165.06%May 14, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
117.18M
from 107.88M
Increased by 8.63%
Revenue Next Year
133.54M
from 117.18M
Increased by 13.96%
EPS This Year
-0.38
from -0.51
EPS Next Year
-0.15
from -0.38
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
22.24M37.05M70.19M90.05M107.88M117.18M
Revenue Growth
20.47%66.62%89.43%28.29%19.80%8.63%
Gross Profit
10.56M19.22M43.93M55.14M69.63M73.39M
Gross Margin
47.50%51.87%62.58%61.23%64.55%62.63%
Operating Income
-27.88M-38.49M-27.33M-24.72M-14.41M-24.93M
Net Income
-29.00M-44.04M-43.10M-38.07M-33.52M-31.29M
EPS
-----0.51-0.38
Free Cash Flow
-14.46M-24.28M-19.28M6.67M-3.66M-4.38M
No. Analysts
-----6
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High140.8M
Avg117.2M
Low111.2M

Revenue Growth

Revenue Growth202620272028
High
30.5%
Avg
8.6%
Low
3.1%

EPS Forecast

EPS202620272028
High-0.38
Avg-0.38
Low-0.38

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-